23 results on '"Meiser, Bruno"'
Search Results
2. Is Cytomegalovirus Prophylaxis Dispensable in Patients Receiving an mTOR Inhibitor–Based Immunosuppression? A Systematic Review and Meta-Analysis
3. Coronary Calcifications Detected by Computed Tomography Are Not Markers of Cardiac Allograft Vasculopathy
4. Mycophenolate and Sirolimus as Calcineurin Inhibitor-Free Immunosuppression Improves Renal Function Better Than Calcineurin Inhibitor-Reduction in Late Cardiac Transplant Recipients With Chronic Renal Failure
5. Impact of Coronary Endothelial Dysfunction on Adverse Long-Term Outcome After Heart Transplantation
6. Levosimendan Treatment After Primary Organ Failure in Heart Transplantation: A Direct Way to Recovery?
7. Conversion to Sirolimus and Mycophenolate Can Attenuate the Progression of Bronchiolitis Obliterans Syndrome and Improves Renal Function after Lung Transplantation
8. Review of Major Clinical Trials with Mycophenolate Mofetil in Cardiac Transplantation
9. The Best Dosing for Initial Tacrolimus Application Is Trough Level Adapted!
10. Tacrolimus or Cyclosporine: Which Is the Better Partner for Mycophenolate Mofetil in Heart Transplant Recipients?
11. BENEFICIAL EFFECTS OF QUINAPRILAT ON CORONARY VASOMOTOR FUNCTION, ENDOTHELIAL OXIDATIVE STRESS, AND ENDOTHELIN ACTIVATION AFTER HUMAN HEART TRANSPLANTATION
12. Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failure
13. The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol1
14. THE CLINICAL IMPACT OF CYCLOSPORINE NEPHROTOXICITY IN HEART TRANSPLANTATION
15. COMPARISON OF TROUGH LEVEL ADJUSTED MMF APPLICATION IN COMBINATION WITH EITHER CYCLOSPORINE OR TACROLIMUS IN A RANDOMIZED STUDY AFTER HEART TRANSPLANTATION.
16. MODULATION OF CORONARY VASOMOTOR TONE BY CYTOKINES IN CARDIAC TRANSPLANT RECIPIENTS
17. OPTIMIZATION OF THE IMMUNOSUPPRESSIVE PROTOCOL AFTER LUNG TRANSPLANTATION1
18. CHIMERIC MONOCLONAL CD4 ANTIBODY—A NOVEL IMMUNOSUPPRESSANT FOR CLINICAL HEART TRANSPLANTATION
19. REDUCTION OF THE INCIDENCE OF REJECTION BY ADJUNCT IMMUNOSUPPRESSION WITH PHOTOCHEMOTHERAPY AFTER HEART TRANSPLANTATION
20. THE IMPORTANCE OF THE SPLEEN FOR THE IMMUNOSUPPRESSIVE ACTION OF CYCLOSPORINE IN TRANSPLANTATION
21. The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol1.
22. THE COMBINATION OF SIROLIMUS AND TACROLIMUS FOR PRIMARY IMMUNOSUPPRESSION AFTER HEART TRANSPLANTATION — 3-YEAR RESULTS.
23. IG-THERASORB IMMUNOAPHERESIS IN ORTHOTOPIC XENOTRANSPLANTATION OF BABOONS WITH LANDRACE PIG HEARTS.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.